American Journal of Neuroradiology 21:105-111 (1 2000)
© 2000 American Society of Neuroradiology
ARTICLE
Visualization of Intravenously Administered Contrast Material in the CSF on Fluid-AttenuatedInversion-Recovery MR Images: An In Vitro and Animal-Model Investigation
a From the Departments of Radiology (A.C.M.), Pathology (P.J.H.), and Clinical Pharmacology (L.D.L.), Dartmouth-Hitchcock Medical Center, Lebanon, NH.
BACKGROUND AND PURPOSE: The FLAIR (fluid-attenuated inversion-recovery) pulse sequence has been shown to be sensitive to abnormalities of the subarachnoid space. Our clinical experience led us to investigate whether intravenously injected contrast material can affect the appearance of the subarachnoid space on FLAIR MR images.
METHODS: After noting unexplained high signal in the subarachnoid space on FLAIR images in a patient, we studied two dogs with sequential FLAIR MR imaging after IV administration of contrast material. A third dog was studied with a 6-hour delayed FLAIR sequence after triple-dose (0.3 mmol/kg) IV contrast administration. CSF was obtained from two animals for measurement of gadolinium concentration. A phantom was developed to determine the lowest concentration at which the effects of gadolinium were evident on FLAIR images in vitro.
RESULTS: In all three animals, the appearance of the CSF in the ventricles or subarachnoid space was modified after administration of IV contrast. This was most evident on delayed images. The CSF samples showed a gadolinium concentration of 0.007 mmol/L in the dog who received the 0.1 mmol/kg dose and 0.02 mmol/L in the dog who received a triple dose. In our in vitro phantom experiments, gadolinium effects were evident on FLAIR images at a concentration four times lower than those on T1-weighted images.
CONCLUSION: IV contrast material can cross into the CSF in sufficient concentration to alter the appearance of the subarachnoid space on FLAIR images in normal dogs. Although we encountered two patients with CNS disease in whom enhancement of the CSF was seen on postcontrast FLAIR images, additional investigation is needed in humans to determine whether enhancement may occur at triple dose in healthy subjects.
This article has been cited by other articles:
 |
|
 |
|
  B.E. Hamilton and G.M. Nesbit Delayed CSF Enhancement in Posterior Reversible Encephalopathy Syndrome AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 456 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.M. Morris and G.M. Miller Increased Signal in the Subarachnoid Space on Fluid-Attenuated Inversion Recovery Imaging Associated with the Clearance Dynamics of Gadolinium Chelate: A Potential Diagnostic Pitfall AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1964 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.M. Levy Exceeding the Limits of the Normal Blood-Brain Barrier: Quo Vadis Gadolinium? AJNR Am. J. Neuroradiol., November 1, 2007; 28(10): 1835 - 1836. [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Stuckey, T. D. Goh, T. Heffernan, and D. Rowan Hyperintensity in the Subarachnoid Space on FLAIR MRI Am. J. Roentgenol., October 1, 2007; 189(4): 913 - 921. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hirai, Y. Ando, M. Yamura, M. Kitajima, Y. Hayashida, Y. Korogi, T. Yamashita, and Y. Yamashita Transthyretin-Related Familial Amyloid Polyneuropathy: Evaluation of CSF Enhancement on Serial T1-Weighted and Fluid-Attenuated Inversion Recovery Images following Intravenous Contrast Administration AJNR Am. J. Neuroradiol., September 1, 2005; 26(8): 2043 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Galassi, W. Phuttharak, J. R. Hesselink, J. F. Healy, R. B. Dietrich, and S. G. Imbesi Intracranial Meningeal Disease: Comparison of Contrast-Enhanced MR Imaging with Fluid-Attenuated Inversion Recovery and Fat-Suppressed T1-Weighted Sequences AJNR Am. J. Neuroradiol., March 1, 2005; 26(3): 553 - 559. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Michel, H. Liu, K. B. Remley, A. J. Martin, M. T. Madison, J. Kucharczyk, and C. L. Truwit Perfusion MR Neuroimaging in Patients Undergoing Balloon Test Occlusion of the Internal Carotid Artery AJNR Am. J. Neuroradiol., September 1, 2001; 22(8): 1590 - 1596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Rai and J. P. Hogg Persistence of Gadolinium in CSF: A Diagnostic Pitfall in Patients with End-stage Renal Disease AJNR Am. J. Neuroradiol., August 1, 2001; 22(7): 1357 - 1361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Taoka, W. T. C. Yuh, M. L. White, J. P. Quets, J. E. Maley, and T. Ueda Sulcal Hyperintensity on Fluid-Attenuated Inversion Recovery MR Images in Patients Without Apparent Cerebrospinal Fluid Abnormality Am. J. Roentgenol., February 1, 2001; 176(2): 519 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Bretschneider, M. Strotzer, I. D. Wilkinson, P. D. Griffiths, N. Hoggard, T. J. Cleveland, P. A. Gaines, and G. S. Venables Leptomeningeal Enhancement and Extravasation of Contrast Medium into the CSF Space? Response to the Preceding 2 Letters Stroke, September 1, 2000; 31 (9): 2266 - 2278. [Full Text] [PDF]
|
|